Eurofarma awarded with Health Leaders’ Prize 2016
Published in: December 7, 2016
and updated in: November 4, 2021
Listen to the text
Stop the audio
Last Tuesday, Grupo Mídia promoted, in the city of São Paulo, the awarding of Health Leaders 2016, homage to last year’s most outstanding companies in the health sector with focus on hospital segment.
The event awarded 3 companies in each of the 23 categories. The winning companies were chosen by Grupo Mídia Editorial Council. In “Pharmaceutical Industry”, Eurofarma was one of the highlights beside EMS and Bayer.
Maria del Pilar Muñoz, executive director of Sustainability and New Business, represented Eurofarma in the event. The full list of winners may be checked in Healthcare Management magazine 45th edition.
About Eurofarma Group
Eurofarma Group is the first Brazilian multinational pharmaceutical with 100% national capital. Acknowledged by the medical community and society for promoting access to health and quality of life with treatments at fair prices, with quality and innovation, is present in 20 countries.
With 45 years of existence and 6,500 collaborators, its position is outstanding in the segments where it operates: Medical Prescription and Over-the-counter, Generic, Hospital, Biddings, Oncology, and Services to Third Parties. Its portfolio comprises over 280 products and, in 2016, over 290 million units of medication were produced. Last year, the Group reached income of R$ 3.3 billion, 15.7% higher than in the previous year.
In 2016, with R$ 141 million in investments and its expertise and agility in Research and Development, it became the pharmaceutical with best performance in portfolio renovation, counting, today, on 176 projects in the pipeline.
For further information, access www.eurofarma.com.br
Information to Press
G&A Public Relations – Clareane Moraes | (11) 3065-3045 | clareane@gaspar.com.br Guilherme Gaspar | (11) 3065-3049 | guilherme@gaspar.com.br
The event awarded 3 companies in each of the 23 categories. The winning companies were chosen by Grupo Mídia Editorial Council. In “Pharmaceutical Industry”, Eurofarma was one of the highlights beside EMS and Bayer.
Maria del Pilar Muñoz, executive director of Sustainability and New Business, represented Eurofarma in the event. The full list of winners may be checked in Healthcare Management magazine 45th edition.
About Eurofarma Group
Eurofarma Group is the first Brazilian multinational pharmaceutical with 100% national capital. Acknowledged by the medical community and society for promoting access to health and quality of life with treatments at fair prices, with quality and innovation, is present in 20 countries.
With 45 years of existence and 6,500 collaborators, its position is outstanding in the segments where it operates: Medical Prescription and Over-the-counter, Generic, Hospital, Biddings, Oncology, and Services to Third Parties. Its portfolio comprises over 280 products and, in 2016, over 290 million units of medication were produced. Last year, the Group reached income of R$ 3.3 billion, 15.7% higher than in the previous year.
In 2016, with R$ 141 million in investments and its expertise and agility in Research and Development, it became the pharmaceutical with best performance in portfolio renovation, counting, today, on 176 projects in the pipeline.
For further information, access www.eurofarma.com.br
Information to Press
G&A Public Relations – Clareane Moraes | (11) 3065-3045 | clareane@gaspar.com.br Guilherme Gaspar | (11) 3065-3049 | guilherme@gaspar.com.br